NYSE:PX • US69376K1060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for P10 INC-A (PX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-13 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-02-13 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-13 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-07 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-12-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-12-09 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-11-11 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2024-11-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-08 | Keefe, Bruyette & Woods | Reiterate | Market Perform -> Market Perform |
| 2024-10-22 | UBS | Maintains | Neutral -> Neutral |
| 2024-10-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-07 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-21 | UBS | Downgrade | Buy -> Neutral |
| 2024-08-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-12 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2024-08-12 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 198.4M 31.83% | 241.734M 21.84% | 296.448M 22.63% | 305.15M 2.94% | 360.74M 18.22% | 408.28M 13.18% | |
| EBITDA YoY % growth | 70.76M -0.34% | 50.88M -28.09% | 87.176M 71.34% | 110.52M 26.78% | 166.96M 51.07% | 118.45M -29.05% | |
| EBIT YoY % growth | 43.4M 7.69% | 20.921M -51.79% | 60.62M 189.76% | 96.975M 59.97% | 164.49M 69.62% | 92.7M -43.64% | |
| Operating Margin | 21.88% | 8.65% | 20.45% | 31.78% | 45.60% | 22.71% | |
| EPS YoY % growth | 0.80 58.51% | 0.84 5.00% | 1.01 20.24% | 0.93 -7.96% | 1.12 20.80% | 1.30 15.57% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.25 -17.26% | 0.25 24.12% | 0.28 22.93% | 0.30 25.96% | 0.31 23.24% | 0.32 28.63% | 0.34 20.22% | 0.36 19.25% | 0.37 21.21% |
| Revenue Q2Q % growth | 80.958M -4.77% | 83.08M 22.78% | 89.734M 23.42% | 92.041M 21.22% | 94.348M 16.54% | 93.184M 12.16% | 100.89M 12.43% | 104.28M 13.30% | 107.81M 14.27% |
| EBITDA Q2Q % growth | 38.625M -21.83% | 39.037M 130.77% | 39.861M 32.95% | 44.29M 49.51% | 43.26M 12.00% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 24.772M 8.38% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
13 analysts have analysed PX and the average price target is 16.96 USD. This implies a price increase of 60.89% is expected in the next year compared to the current price of 10.54.
P10 INC-A (PX) will report earnings on 2026-05-07, after the market close.
The consensus EPS estimate for the next earnings of P10 INC-A (PX) is 0.25 USD and the consensus revenue estimate is 80.96M USD.
The expected long term growth rate for P10 INC-A (PX) is 11.06%.